Company Ardea Biosciences, Inc.
Equities
US03969P1075
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2012 | SANOFI : AstraZeneca hungry to refill medicine cabinet | RE |
2012 | SANOFI : GSK goes hostile with $2.6 billion Human Genome offer | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,861,180 | 36,861,180 ( 100.00 %) | 0 | 100.00 % |
Sector
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+18.31% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- Stock
- Company Ardea Biosciences, Inc.